Group 1 - The company announced the signing of a structured deposit agreement with Bank of China on January 6, 2026, agreeing to subscribe to a structured deposit amounting to RMB 980 million [1] - The company also signed a structured deposit agreement with Bank of Communications on January 6, 2026, agreeing to subscribe to a structured deposit amounting to RMB 400 million [1]

Core Viewpoint - The company, Kelun-Biotech (06990.HK), has entered into structured deposit agreements with two banks, indicating a strategic move to manage its cash reserves effectively [1] Group 1: Structured Deposit Agreements - The company has agreed to subscribe to a structured deposit with Bank of China amounting to RMB 980 million [1] - Additionally, the company has entered into a structured deposit agreement with China Construction Bank for RMB 400 million [1]

Group 1 - Company Kelong Botai Biotech-B (06990) announced the signing of a structured deposit agreement with Bank of China on January 6, 2026, agreeing to subscribe to a structured deposit amounting to RMB 980 million [1] - On the same date, the company also entered into a structured deposit agreement with China Transportation Bank, agreeing to subscribe to a structured deposit of RMB 400 million [1]

Core Points - Yangzhou Jinqian (603307) announced the use of part of its temporarily idle raised funds for cash management on August 18 [1] - The company purchased structured deposits from Bank of Communications amounting to 30 million yuan, which were redeemed recently, recovering the principal of 30 million yuan and earning a profit of 153,041.10 yuan [1] - The total amount used for cash management products is 95 million yuan, with an unused quota of 55 million yuan remaining [1]